Coya Therapeutics, Inc. (COYA)
USD 6.37
(1.43%)
USD 6.37
(1.43%)
| Breakdown | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|
| Operating Cash Flow | -11.18 Million | -7.23 Million | -3.9 Million | -391.26 Thousand |
| Net Income | -7.98 Million | -12.24 Million | -4.89 Million | -733.19 Thousand |
| Depreciation & Amortization | 27.36 Thousand | 27.36 Thousand | 16.13 Thousand | - |
| Deferred income taxes | -298.81 Thousand | - | 399.67 Thousand | - |
| Stock-based compensation | 872.24 Thousand | 207.34 Thousand | 233.22 Thousand | - |
| Change in working capital | -4.64 Million | 751.83 Thousand | 739.16 Thousand | 77.95 Thousand |
| Other non-cash items | 842 Thousand | 4.01 Million | -399.67 Thousand | 158.75 Thousand |
| Investing Cash Flow | -543.18 Thousand | -525 Thousand | -136.8 Thousand | - |
| Investments in PPE | 1.00 | - | -136.8 Thousand | - |
| Acquisitions | - | - | - | - |
| Investment purchases | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - |
| Other Investing Activities | -543.18 Thousand | -525 Thousand | - | - |
| Financing Cash Flow | 38.42 Million | 9.35 Million | -340.58 Thousand | 9.11 Million |
| Debt repayment | - | -9.47 Million | - | - |
| Dividends payments | - | - | - | - |
| Common Stock Repurchased | - | - | - | - |
| Common Stock Issuance | 38.42 Million | 158.00 | 1317.00 | 9.11 Million |
| Other Financing Activities | 14.34 Million | 18.82 Million | -341.9 Thousand | 400.00 |
| Accounts receivables | -7.5 Million | - | - | - |
| Accounts payables | 298.81 Thousand | 845.28 Thousand | 665.16 Thousand | 105.22 Thousand |
| Inventory | - | - | - | - |
| Other working capital | 2.55 Million | -93.44 Thousand | 74 Thousand | -27.26 Thousand |
| Cash at beginning of period | 5.93 Million | 4.34 Million | 8.72 Million | - |
| Cash at end of period | 32.62 Million | 5.93 Million | 4.34 Million | 8.72 Million |
| Capital Expenditure | 1.00 | - | -136.8 Thousand | - |
| Effect of forex changes on cash | - | - | - | - |
| Net cash flow / Change in cash | 26.69 Million | 1.59 Million | -4.38 Million | 8.72 Million |
| Free Cash Flow | -11.18 Million | -7.23 Million | -4.04 Million | -391.26 Thousand |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -4.02 Million | -2.89 Million | -5.05 Million | -7.98 Million | 1.26 Million | -3.42 Million |
| Depreciation & Amortization | 6841.00 | 6840.00 | 6840.00 | 27.36 Thousand | 6840.00 | 6841.00 |
| Deferred income taxes | - | - | - | -298.81 Thousand | 225.04 Thousand | 119.93 Thousand |
| Stock-based compensation | 775 Thousand | 662.32 Thousand | 435.66 Thousand | 872.24 Thousand | 237.99 Thousand | 262.75 Thousand |
| Change in working capital | -4.38 Million | -2.34 Million | 6.73 Million | -4.64 Million | -3.94 Million | 936.27 Thousand |
| Other non-cash items | 2.16 Million | 437.19 Thousand | -7.5 Million | 842 Thousand | -31.86 Thousand | -119.93 Thousand |
| Investing Cash Flow | 25 Thousand | - | -25 Thousand | -543.18 Thousand | -193.18 Thousand | - |
| Investments in PPE | 25 Thousand | -3.00 | -25 Thousand | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | -25 Thousand | -543.18 Thousand | -193.18 Thousand | - |
| Financing Cash Flow | -56.33 Thousand | 5.14 Million | 1.24 Million | 38.42 Million | 24.17 Million | - |
| Debt repayment | -11.25 Thousand | - | -11.25 Thousand | - | -28.5 Million | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | -1.43 Million | 5.14 Million | 1.23 Million | 38.42 Million | 24.17 Million | - |
| Other Financing Activities | 1.39 Million | 149.25 Thousand | -120.66 Thousand | 14.34 Million | 24.17 Million | - |
| Accounts receivables | -7.5 Million | - | 7.5 Million | -7.5 Million | - | - |
| Accounts payables | -1.49 Million | 238.8 Thousand | 477.26 Thousand | 298.81 Thousand | 476.72 Thousand | 396.37 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | 3.82 Million | -2.57 Million | -1.24 Million | 2.55 Million | -4.42 Million | 539.89 Thousand |
| Cash at beginning of period | 36.57 Million | 35.98 Million | 32.62 Million | 5.93 Million | 10.88 Million | 13.1 Million |
| Cash at end of period | 31.05 Million | 36.57 Million | 35.98 Million | 32.62 Million | 32.62 Million | 10.88 Million |
| Capital Expenditure | 25 Thousand | -3.00 | -25 Thousand | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -5.51 Million | 585.68 Thousand | 3.36 Million | 26.69 Million | 21.74 Million | -2.21 Million |
| Free Cash Flow | -5.43 Million | -4.56 Million | 2.12 Million | -11.18 Million | -2.24 Million | -2.21 Million |
600737
NEMTF
SUZ
PRM
CRAYN
COIHY